Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Nov 24, 2021 10:47am
153 Views
Post# 34161366

Uncollected receivables of $ 25 million are troublesome

Uncollected receivables of $ 25 million are troublesomeThe company generated $ 25 million in sales in Q3 and, there accounts receivable are $ 25 million.

If I am doing the math, it means that they collected NADA or ZERO from their sales?

The average test is $ 150 per patient, it should not take 120 days to get paid.   At my dentist, a $ 150 bill with the insurance company takes at most 3 weeks to pay, sometimes it is done in 10 days.

So I see issues with this $ 25 million in receivables, some of which begins to date from July 1, 2021.    We are November 24th, and, on October 31st these amounts were still not collected.

I have to ask, why would a creditor accept 6,300,000 shares as payment for a $ 411,000 amount, when the company is supposed to be flush with cash?   It does not make sense.   And why would the creditor lock themselves in for 4 months with these shares, which can plunge belong their acquistion cost of 7 cents per share.

It is a huge blur to me.    Now we are hearing that November 2021 has slowed down.   This is from Sarb999 who claims that he heard it from the company.

Myself I am expecting write-offs against these receivables due to complaints, due to non delivery of tests, due to late tests, due to never doing the tests, etc....  To get thrown out of East Hampton and to be under investigation with 2 cubes in California is very telling. 

My personal opinion
<< Previous
Bullboard Posts
Next >>